Jóhannes Reynisson

Cited by

	All	Since 2017
Citations	3791	2501
h-index	35	27
i10-index	90	76

680

340

170

510

20022003200420052006200720082009201020112012201320142015201620172018201920202021202210 15 27 45 38 33 56 65 83 98 122 107 150 156 260 327 320 439 417 667 330

Public access

View all

15 articles

10 articles

available

not available

Based on funding mandates

Co-authors

Olga LavrikProfessor, Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk State UniversityVerified email at niboch.nsc.ru
Euphemia LeungUniversity of AucklandVerified email at auckland.ac.nz
David BarkerAssociate Professor, The University of AucklandVerified email at aucklanduni.ac.nz
Ayesha ZafarUniversity of AucklandVerified email at aucklanduni.ac.nz
Lisa I. PilkingtonSenior LecturerVerified email at aucklanduni.ac.nz
Christian HartingerProfessor of Chemistry, University of AucklandVerified email at aucklanduni.ac.nz
Suslov EvgeniyФедеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН)Verified email at nioch.nsc.ru
Margaret Anne BrimbleSchool of Biological Sciences, School of Chemical Sciences, the University of Auckland,Verified email at auckland.ac.nz
Paul WorkmanChief Executive & President, Institute of Cancer Research, LondonVerified email at icr.ac.uk
Naresh SinghalAssociate Professor of Environmental Engineering, University of AucklandVerified email at auckland.ac.nz
Viji SarojiniUniversity of AucklandVerified email at auckland.ac.nz
Vedrana Cikes CulicUniversity of Split School of MedicineVerified email at mefst.hr
Waseeq SiddiquiUniversity of SargodhaVerified email at uos.edu.pk
Nikolina Režić MužinićUniversity of Split School of MedicineVerified email at mefst.hr
Anita MarkotićUniversity of Split School of Medicine unist.hrVerified email at mefst.hr
Michael P HayAssociate Professor, University of AucklandVerified email at auckland.ac.nz
Inga ReynisdóttirCell Biology Unit, Department of Pathology, Landspitali-University Hospital, IcelandVerified email at landspitali.is
yacine hemarThe University of AucklandVerified email at auckland.ac.nz
Kurt V. MikkelsenProfessor of Theoretical Chemistry, Department of Chemistry, University of CopenhagenVerified email at chem.ku.dk
Emily Hargrave-ThomasPhD Candidate in Chemical and Materials Engineering, Auckland UniversityVerified email at auckland.ac.nz

Jóhannes Reynisson

School of Pharmacy, Keele University, United Kingdom

Verified email at keele.ac.uk - Homepage

Drug discovery molecular modelling Known Drug Space virtual screening


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Benchmarking the reliability of QikProp. Correlation between experimental and predicted values L Ioakimidis, L Thoukydidis, A Mirza, S Naeem, J Reynisson QSAR & Combinatorial Science 27 (4), 445-456, 2008	202	2008
Sorption and biodegradation of organic micropollutants during river bank filtration: A laboratory column study C Bertelkamp, J Reungoat, ER Cornelissen, N Singhal, J Reynisson, ... Water research 52, 231-241, 2014	150	2014
Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action MV Babak, SM Meier, KVM Huber, J Reynisson, AA Legin, MA Jakupec, ... Chemical science 6 (4), 2449-2456, 2015	121	2015
Characteristics of known drug space. Natural products, their derivatives and synthetic drugs R Bade, HF Chan, J Reynisson European journal of medicinal chemistry 45 (12), 5646-5652, 2010	114	2010
Hit generation and exploration: imidazo [4, 5-b] pyridine derivatives as inhibitors of Aurora kinases V Bavetsias, C Sun, N Bouloc, JÛ Reynisson, P Workman, ... Bioorganic & medicinal chemistry letters 17 (23), 6567-6571, 2007	112	2007
Intercalation of trioxatriangulenium ion in DNA: binding, electron transfer, X-ray crystallography, and electronic structure J Reynisson, GB Schuster, SB Howerton, LD Williams, RN Barnett, ... Journal of the American Chemical Society 125 (8), 2072-2083, 2003	103	2003
Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety A Zakharenko, T Khomenko, S Zhukova, O Koval, O Zakharova, ... Bioorganic & Medicinal Chemistry 23 (9), 2044-2052, 2015	95	2015
Anticancer Ruthenium(η⁶-p-cymene) Complexes of Nonsteroidal Anti-inflammatory Drug Derivatives F Aman, M Hanif, WA Siddiqui, A Ashraf, LK Filak, J Reynisson, ... Organometallics 33 (19), 5546-5553, 2014	93	2014
DFT calculations on the electrophilic reaction with water of the guanine and adenine radical cations. A model for the situation in DNA J Reynisson, S Steenken Physical Chemistry Chemical Physics 4 (3), 527-532, 2002	89	2002
Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical … V Bavetsias, JM Large, C Sun, N Bouloc, M Kosmopoulou, M Matteucci, ... Journal of medicinal chemistry 53 (14), 5213-5228, 2010	85	2010
Synthesis and cytotoxicity of thieno [2, 3-b] pyridine and furo [2, 3-b] pyridine derivatives JM Hung, HJ Arabshahi, E Leung, J Reynisson, D Barker European journal of medicinal chemistry 86, 420-437, 2014	70	2014
New water-soluble copper (II) complexes with morpholine–thiosemicarbazone hybrids: Insights into the anticancer and antibacterial mode of action K Ohui, E Afanasenko, F Bacher, RLX Ting, A Zafar, N Blanco-Cabra, ... Journal of medicinal chemistry 62 (2), 512-530, 2018	65	2018
Investigation of the incidence of “undesirable” molecular moieties for high-throughput screening compound libraries in marketed drug compounds P Axerio-Cilies, IP Castañeda, A Mirza, J Reynisson European journal of medicinal chemistry 44 (3), 1128-1134, 2009	65	2009
Half‐Sandwich Ruthenium (II) Biotin Conjugates as Biological Vectors to Cancer Cells MV Babak, D Plażuk, SM Meier, HJ Arabshahi, J Reynisson, B Rychlik, ... Chemistry–A European Journal 21 (13), 5110-5117, 2015	63	2015
The effect of PLC-γ2 inhibitors on the growth of human tumour cells L Feng, I Reynisdóttir, J Reynisson European journal of medicinal chemistry 54, 463-469, 2012	61	2012
Mutagenicity and DNA adduct formation by the urban air pollutant 2-nitrobenzanthrone VM Arlt, H Glatt, G Gamboa da Costa, J Reynisson, T Takamura-Enya, ... Toxicological sciences 98 (2), 445-457, 2007	59	2007
New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties T Khomenko, A Zakharenko, T Odarchenko, HJ Arabshahi, V Sannikova, ... Bioorganic & Medicinal Chemistry 24 (21), 5573-5581, 2016	58	2016
DFT studies on the pairing abilities of the one-electron reduced or oxidized adenine–thymine base pair J Reynisson, S Steenken Physical Chemistry Chemical Physics 4 (21), 5353-5358, 2002	54	2002
The identification of novel PLC-[gamma] inhibitors using virtual high throughput screening JÛ Reynisson, C O'Neill, J Day, L Patterson, E McDonald, P Workman, ... Bioorganic & medicinal chemistry 17 (8), 3169-3176, 2009	52*	2009
2, 6, 10-Tris (dialkylamino) trioxatriangulenium salts: a new promising fluorophore. Ion-pair formation and aggregation in non-polar solvents BW Laursen, J Reynisson, KV Mikkelsen, K Bechgaard, N Harrit Photochemical & Photobiological Sciences 4 (8), 568-576, 2005	52	2005

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors